Evidence map›Paper›PMID 41438624›Full record

ArticleIJID regions2025

Oropouche fever: Clinical characteristics and viral-bacterial coinfections in a region of the Peruvian Amazon: A cross-sectional study.

Wilmer Silva-Caso, Giancarlo Pérez-Lazo, Miguel Angel Aguilar-Luis, Ronald Aquino-Ortega, Yordi Tarazona-Castro, Fernando Soto-Febres, Luis J Del Valle, Jhonathan Bazalar-Gonzales, Kocfa Chung-Delgado, Ivonne Melissa Ramírez and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wilmer Silva-CasoLaboratorio de Biomedicina, Centro de Investigación de la Facultad de Ciencias de la Salud, Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Peru.
Giancarlo Pérez-LazoDivision of Infectious Diseases, Guillermo Almenara Irigoyen National Hospital, EsSalud, Lima, Peru.
Miguel Angel Aguilar-LuisLaboratorio de Biomedicina, Centro de Investigación de la Facultad de Ciencias de la Salud, Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Peru.
Ronald Aquino-OrtegaLaboratorio de Biomedicina, Centro de Investigación de la Facultad de Ciencias de la Salud, Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Peru.
Yordi Tarazona-CastroLaboratorio de Biomedicina, Centro de Investigación de la Facultad de Ciencias de la Salud, Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Peru.
Fernando Soto-FebresDivision of Infectious Diseases, Guillermo Almenara Irigoyen National Hospital, EsSalud, Lima, Peru.
Luis J Del ValleCentre d'Enginyeria Biotecnologica i Molecular (CEBIM), Departament d'Enginyeria Quıímica, ETSEIB, Universidad Politécnica de Catalunya (UPC), Barcelona Tech, Spain.
Jhonathan Bazalar-GonzalesAsociación Equipo Primatológico del Perú, Iquitos, Perú.
Kocfa Chung-DelgadoEscuela de Medicina, Facultad de Ciencias de la Salud, Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Peru.
Ivonne Melissa RamírezCentro de Investigaciones Tecnológicas, Biomedicas y Medioambientales, Bellavista, Perú.
Sami AlcedoInstitute of Tropical Medicine, (ITM), Department of Clinical Sciences, Antwerp, Belgium.
Roxana SandovalDepartamento de Patología Clínica Guillermo Almenara Irigoyen National Hospital, EsSalud, Lima, Peru.
Juana Del Valle-MendozaLaboratorio de Biomedicina, Centro de Investigación de la Facultad de Ciencias de la Salud, Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Peru.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Cocirculation of Oropouche virus (OROV) with other endemic pathogens means coinfections can occur. This study aimed to characterize viral and bacterial coinfections in OROV-positive patients, evaluating their clinical features and exploring the impact on hospital stay and antibiotic use across different infection groups. Methods: Cross-sectional study in an eastern Peruvian Amazon region among patients with acute febrile illness who tested positive for OROV. Patients were stratified into five groups: OROV monoinfection, OROV + dengue virus serotype 2 (DENV-2): American/Asian II coinfection, OROV + Results: A total of 75 patients were included. Patients with OROV + Conclusions: Coinfection with

Indexed as

CoinfectionCorrespondence antibioticDengueLeptospiraOropoucheRickettsia

Identifiers

PMID41438624
PMCPMC12719223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.